Apple HT208931 Smart Watch Instruction Manual

Apple HT208931 Smart Watch

The Irregular Rhythm Notification Feature (IRNF) is a software-only mobile medical application that is intended to be used with the Apple Watch. The feature analyzes pulse rate data to identify episodes of irregular heart rhythms suggestive of atrial fibrillation (AFib) and provides a notification to the user. The feature is intended for over-the-counter (OTC) use. It is not intended to provide a notification on every episode of irregular rhythm suggestive of AFib and the absence of a notification is not intended to indicate no disease process is present; rather the feature is intended to opportunistically surface a notification of possible AFib when sufficient data are available for analysis. These data are only captured when the user is still. Along with the userʼs risk factors, the feature can be used to supplement the decision for AFib screening. The feature is not intended to replace traditional methods of diagnosis or treatment. The feature has not been tested for and is not intended for use in people under 22 years of age. It is also not intended for use in individuals previously diagnosed with AFib.

RUSSIA COUNTRY-SPECIFIC INFORMATION

The Irregular Rhythm Notification Feature is not considered a medical device per ROSZDRAVNADZOR (Russian Health Authority) The Irregular Rhythm Notification Feature is a software-only application that is intended to be used with the Apple Watch. The feature analyzes pulse rate data to identify episodes of irregular heart rhythms suggestive of atrial fibrillation (AFib) and provides a notification to the user. The feature is intended for over-the-counter (OTC) use. It is not intended to provide a notification on every episode of irregular rhythm suggestive of AFib and the absence of a notification is not intended to indicate no disease process is present; rather the feature is intended to opportunistically surface a notification of possible AFib when sufficient data are available for analysis. These data are only captured when the user is still. Along with the user risk factors, the feature can be used to supplement the decision for AFib screening. The feature is not intended to replace traditional methods of diagnosis or treatment. The feature has not been tested for and is not intended for use in people under 22 years of age. It is also not intended for use in individuals previously diagnosed with AFib.

USING THE IRREGULAR RHYTHM NOTIFICATION

Set-Up/On-boarding

  • The Irregular Rhythm Notification Feature is compatible with Apple Watch Series 3, Series 4, Series 5, Series 6, Series 7, and SE. For region availability and device compatibility for the IRNF, please visit https://support.apple.com/HT208931
  • Update Apple Watch and iPhone to the latest OS.
  • Open the Health app on your iPhone and select “Browse”.
  • Navigate to “Heart”, then select “Irregular Rhythm Notifications”.
  • Follow the onscreen instructions and complete the onboarding procedure.
  • You may exit onboarding at any time by tapping “Cancel”.

Receiving a Notification

  • Once the feature is turned on, you will receive a notification if the feature identified a heart rhythm suggestive of AFib and confirmed it on multiple readings.
  • If you have not been diagnosed with AFib by a physician, you should discuss the notification with your doctor.

All data collected and analyzed by the Irregular Rhythm Notification Feature is saved to the Health app on your iPhone. If you choose to, you can share that information by exporting your health data in the Health app.  New data cannot be collected once your Apple Watchʼs storage is full. You should free up space by deleting unwanted apps, music, or podcasts. You can check your storage usage by navigating to the Apple Watch app on your iPhone, tapping “My Watch”, tapping “General”, and then tapping “Storage”.

SAFETY AND PERFORMANCE

The performance of the Irregular Rhythm Notification Feature (IRNF) was extensively tested in a clinical study of 573 participants ages 22 and older with a mix of diagnosed AFib and no known history of AFib. Study demographic characteristics are summarized in the table below: IRNF 2.0 Clinical Study Subject Demographics

Enrolled subjects wore an Apple Watch and a reference electrocardiogram (ECG) patch concurrently for up to 13 days. For those subjects contributing data to the primary endpoint analysis, 32.4%
(n=140/432) presented with AFib as identified on the reference ECG patch and were included in determining the device sensitivity. Of those, 124 received an IRNF irregular rhythm notification with concordant AFib on the ECG patch, and the sensitivity was 88.6%. Of the 292 subjects who did not present with AFib on the ECG patch and contributed data to the analysis of device specificity, 290 did not receive a notification. The AF detection specificity was 99.3%. The remaining subjects (n=141/573) either contributed data to only secondary endpoint analyses and/or did not complete the study. These results support the deviceʼs effectiveness in detecting AFib.

CAUTIONS

The Irregular Rhythm Notification Feature cannot detect heart attacks. If you ever experience chest pain, pressure, tightness, or what you think is a heart attack, call emergency services. The Irregular Rhythm Notification Feature is not constantly looking for AFib and should not be relied on as a continuous monitor. This means the feature cannot detect all instances of AFib, and people with AFib may not get a notification.

Apple Watch may be unable to collect data when Apple Watch is in close vicinity to strong electromagnetic fields (e.g. electromagnetic anti-theft systems, metal detectors). A number of factors can impact the ability of the feature to measure your pulse and detect an irregular rhythm suggestive of AFib. These include factors like motion, hand and finger movements, environmental factors such as ambient temperature, dark tattoos on the wrist, and the amount of blood flow to your skin (which can be reduced by cold temperatures). DO NOT wear your Apple Watch during a medical procedure (e.g., magnetic resonance imaging, diathermy, lithotripsy, cautery, and external defibrillation procedures). DO NOT change your medication without talking to your doctor. Not intended for use by individuals under age 22. Not intended for use by individuals previously diagnosed with AFib. Notifications made by this feature are potential findings, not a complete diagnosis of cardiac conditions. All notifications should be reviewed by a medical professional for clinical decision-making. Apple does not guarantee that you are not experiencing an arrhythmia or other health conditions even in the absence of an irregular rhythm notification. You should notify your physician if you experience any changes to your health. For best results, charge your Apple Watch regularly and make sure it fits snugly on top of your wrist. The heart rate sensor should stay close to your skin

This is a notice to the user and/or patient that any serious incident that has occurred in relation to the IRNF device should be reported to the manufacturer (Apple) and the competent authority of the Member State in which the user and/or patient is established.
SECURITY: Apple recommends that you add a passcode (personal identification number [PIN]), Face ID or Touch ID (fingerprint) to your iPhone, and a passcode (personal identification number [PIN]) to your Apple Watch to add a layer of security. It is important to secure the iPhone since you will be storing personal health information. Users will also receive additional iOS and watchOS update notifications on their iPhone and Apple Watch, and updates are delivered wirelessly, encouraging rapid adoption of the latest security fixes. See “iOS and watchOS Security Guide” which describes Appleʼs security practices and is available to all of our users. For the iOS and watchOS Security Guide please visit https://support.apple.com/guide/security/welcome/web.

EQUIPMENT SYMBOLS

099-30417, Revision B, December 2021